Top must-read Biopharma 4.0 articles
Stay informed about the latest Life Science industry research embracing Biopharma 4.0 principles
En bref
- Curated learning resource: Provides direct access to a collection of recent, high-impact articles to accelerate understanding of Biopharma 4.0 concepts and innovations.
- Expert insights: Includes commentary from industry professionals highlighting what they found valuable in each article, offering readers practical takeaways and perspectives.
- Broad topical coverage: Covers a wide range of themes—from AI and digital twins to single-use technologies and PAT—supporting diverse learning goals across the biopharma landscape.
- Quick navigation: Designed for ease of use, with article summaries and links that help readers quickly find content relevant to their interests and professional development.
Top 20 Biopharma 4.0 articles*
Want to stay ahead in Biopharma 4.0? Explore this expertly curated list of 20 must-read articles covering the latest innovations and trends in the field. Each article includes a concise summary and direct access to the original source, making it easy to dive into topics like machine learning, automation, and single-use technologies. Many entries also feature expert commentary to highlight key takeaways and accelerate your learning.
*The articles in this list are not presented in any particular ranked order.
1. Role of Artificial Intelligence in Revolutionizing Drug Discovery
Authors: Ashfaq Ur Rehman, Mingyu Li, Binjian Wu, Yasir Ali, Salman Rasheed, Sana Shaheen e, Xinyi Liu, Ray Luo, Jian Zhang
Our LSI expert's opinion
"This article offers a compelling overview of how AI is transforming drug discovery and biopharmaceutical manufacturing. I was particularly impressed by its clear articulation of how machine learning enhances process efficiency and product quality, while deepening our understanding of complex biological systems. It's a timely and insightful contribution to the evolving intersection of data science and drug development."
- Maryann Cuellar, Life Science Industry Manager, Endress+Hauser
Source: Fundamental Research (accessed via Science Direct)
2. Future-Proofing the Bioprocessing Sector As It Embraces Industry 4.0 Principles - Part 1
(Full title: A Methodology for Identifying Current and Future Skills Gaps: Future-Proofing the Bioprocessing Sector As It Embraces Industry 4.0 Principles, Part 1)
Authors: Jason Beckwith, Robbie Dool, Paul Rooney, Manish Thilagar, Stephen Goldrick, William Nixon, Stavros Kourtzidis
Summary: Part 1 in this article series discusses identifying skill gaps in the bioprocessing sector as it adopts Industry 4.0 principles, emphasizing the need for new competencies in automation, data analytics, and cybersecurity.
Source: BioProcess International
3. Future-Proofing the Bioprocessing Sector As It Embraces Industry 4.0 Principles - Part 2
(Full title: A Methodology for Identifying Current and Future Skills Gaps: Future-Proofing the Bioprocessing Sector As It Embraces Industry 4.0 Principles, Part 2)
Authors: Jason Beckwith, Paul Rooney, Gregor Adams, Stephen Goldrick, William Nixon, Stavros Kourtzidis
Summary: Part 2 in this series outlines strategies to identify and address skills gaps in the bioprocessing sector, emphasizing the need for new competencies to leverage Industry 4.0 technologies effectively.
Source: BioProcess International
4. Biopharma 4.0 — the Talent Evolution
Authors: Jason Beckwith, Robbie Dool, Paul Rooney, Manish Thilagar, Stephen Goldrick, William Nixon, Stavros Kourtzidis
Summary: This article studies the need for new skills in Biopharma 4.0, emphasizing data science, AI, and automation to meet the evolving demands of biomanufacturing.
Source: BioProcess International
5. AI-Enabled Digital Twins in Biopharmaceutical Manufacturing
Authors: Toni Manzano, William Whitford
Summary: This article highlights how AI-enabled digital twins enhance biopharmaceutical manufacturing by optimizing processes, improving real-time monitoring, and enabling predictive maintenance.
Source: BioProcess International
6. Biopharma Taps Bioprocessing 4.0, Benefits Start Flowing
Author: Gareth John Macdonald
Our LSI expert's opinion
"I thought this article did an excellent job of demonstrating how companies are adopting Biopharma 4.0 technologies. It thoroughly examines how data-driven decisions and inline analysis systems are enhancing speed, flexibility, and efficiency throughout the product lifecycle for many leading biomanufacturers."
- Maryann Cuellar, Life Science Industry Manager, Endress+Hauser
7. The Role of Raman Spectroscopy in Biopharmaceuticals from Development to Manufacturing
Authors: Karen A. Esmonde-White, Maryann Cuellar, and Ian R. Lewis
Our LSI expert's opinion
"I wrote my first review of Raman in bioprocessing in 2017, noticing that there had been a dearth of reviews on the topic since it was last mentioned in 2010. I was not expecting to write another review on this topic so quickly after the first review! But the field has been moving so quickly, with new reports of applications from early discovery to downstream bioprocessing to digital twins, that an updated review was certainly merited. I especially appreciate how this newer review shows the rapid acceptance of Raman in upstream bioprocessing, growing comfort with the technology, and emerging applications driven by the biopharmaceutical industry."
- Karen Esmonde-White, PhD, Product Manager, Endress+Hauser
Source: Analytical Bioanalytical Chemistry (accessed via Springer Nature)
8. A Roadmap to AI-driven In Silico Process Development: Bioprocessing 4.0 in Practice
Authors: Moritz von Stosch, Rui MC Portela, Christos Varsakelis
Summary: This article discusses hybrid modeling in biopharmaceutical processes, highlighting its advantages, implementation steps, and its role in enhancing efficiency and strategic development in the industry.
Source: Current Opinion in Chemical Engineering (accessed via Science Direct)
9. Transformation of Biopharmaceutical Manufacturing Through Single-Use Technologies: Current
State, Remaining Challenges and Future Devt.
Authors: Jasmin J. Samaras, Martina Micheletti, and Weibing Ding
Summary: This article explores how single-use technologies are transforming biopharmaceutical manufacturing, enhancing process efficiency and flexibility, while addressing challenges in materials science and system standardization.
10. Raman Spectrometric PAT Models: Successful Transfer from Minibioreactors to Larger-Scale, Stirred-Tank Bioreactors
Authors: Jens Classen, Matthaeus Langer, Alexander Jockwer, Jens Traenkle
Summary: This article details the successful transfer of Raman spectrometric PAT models from mini-bioreactors to larger-scale stirred-tank bioreactors, enhancing bioprocess monitoring and control.
Source: BioProcess International
11. Systematic Assessment of Process Analytical Technologies for Biologics
Authors: Christopher Gillespie, Dhanuka P. Wasalathanthri, Diana B. Ritz, George Zhou, Keith A. Davis, Thomas Wucherpfennig, Nadine Hazelwood
Summary: This article highlights how PAT can optimize antibody purification by monitoring variable region interactions with Protein A, thus improving elution pH control and streamlining therapeutic antibody production.
Source: Biotechnology and Bioengineering (accessed via Wiley Online Library)
12. The Race to Develop the Pfizer-BioNTech COVID-19 Vaccine: From the Pharmaceutical Scientists’ Perspective
Authors: Lavinia M Lewis, Advait Badkar, David Cirelli, Rodney Combs, Thomas F. Lerch
Our LSI expert's opinion
"Impactful papers tell a story, in addition to reporting on data and results. For me, this paper underscores the incredible work of thousands to produce a safe and effective Covid-19 vaccine. It gave me a new appreciation for the many years spent to develop mRNA technology prior to 2020 and then the full cooperation of science, manufacturing engineering, and regulation to quickly bring a vaccine to patients."
- Karen Esmonde-White, PhD, Product Manager, Endress+Hauser
13. Biopharmaceutical Manufacturing: Historical Perspectives and Future Directions
Authors: Alana C. Szkodny and Kelvin H. Lee
Our LSI expert's opinion
“The authors provide a thoughtful and well-researched perspective on the evolution of biopharmaceutical manufacturing. I found the connection between historical milestones and current innovations particularly compelling, especially the shift toward platform processes and adaptive regulatory frameworks. It’s a valuable resource for understanding how the industry has matured and where it's headed."
- Maryann Cuellar, Life Science Industry Manager, Endress+Hauser
14. Hybrid Modeling for Biopharmaceutical Processes: Advantages, Opportunities, and Implementation
Authors: Harini Narayanan, Moritz von Stosch2, Fabian Feidl, Michael Sokolov, Massimo Morbidelli, Alessandro Butté
Summary: Explores hybrid modeling in biopharmaceutical processes, detailing its benefits, implementation steps, and its potential to enhance efficiency and strategic development in the industry.
15. Ten Battlegrounds for Digital and Analytics in Life Sciences
Authors: Alex Devereson, Chris Llewellyn, Dan Tinkoff, and Manola Vyaravanh
Summary: This article identifies ten key areas where digital and analytics can transform life sciences, emphasizing holistic approaches to innovation, clinical trials, and commercialization for substantial value creation.
Source: McKinsey & Company
16. Digital Twins in Pharmaceutical and Biopharmaceutical Manufacturing: A Literature Review
Authors: Yingjie Chen, Ou Yang, Chaitanya Sampat, Pooja Bhalode, Rohit Ramachandran, and Marianthi Ierapetritou
Summary: This article highlights digital twins’ potential in pharma and biopharma, noting gaps in PAT accuracy, real-time computation, and data security, and suggests solutions like NIRS, UV or Raman spectroscopy, and adaptive modeling.
Source: MDPI Open Access Journals
17. Biopharmaceutical Benchmarks 2022
Authors: Gary Walsh and Eithne Walsh
Our LSI expert's opinion
"Professor Walsh has been publishing a survey on the status of biopharmaceuticals every four years since 2010. These surveys were very helpful for me to learn about the broad trends and important factors in advancing upstream biopharmaceuticals. I also refer to these articles routinely as a refresher and eagerly anticipate a new addition to this important series."
- Karen Esmonde-White, PhD, Product Manager, Endress+Hauser
Source: Nature Biotechnology
18. Rise of Single-Use Bioprocessing Technologies: Dominating Most R&D and Clinical Manufacture
Authors: K. John Morrow, Jr. and Eric S. Langer
Summary: This article discusses how single-use bioprocessing technologies are increasingly being adopted in R&D and clinical manufacturing, offering flexibility and cost savings, though commercial adoption is slower due to regulatory and scalability challenges.
Source: American Pharmaceutical Review
19. Utilizing Biopharma 4.0 to Boost Coronavirus 2019-nCoV Vaccine Efforts
Authors: GEN staff
Summary: This article explores how Biopharma 4.0 technologies, including AI and automation, was accelerating COVID-19 vaccine development, enhancing manufacturing efficiency, and ensuring rapid response to future pandemics.
20. Understanding Pharmaceutical Quality by Design
Authors: Lawrence X. Yu, Gregory Amidon, Mansoor A. Khan, Stephen W. Hoag, James Polli, G. K. Raju, Janet Woodcock
Our LSI expert's opinion
"Need an introduction to Quality by Design (QbD) and its many acronyms? This paper is a terrific reference that will guide you through the regulatory support of QbD and the processes to support the QbD framework. I especially appreciated the step-by-step guide on starting with the Quality Target Product Profile (QTPP), linking the critical material attributes (CMA) and critical quality attributes (CQA) to the QTPP, and defining the critical process parameters (CPP) to achieve the CMA or CQA."
- Karen Esmonde-White, PhD, Product Manager, Endress+Hauser
Source: National Library of Medicine | PMC
Free downloadable resource
Download the entire article collection
Accelerate your Biopharma 4.0 learning with this expertly curated collection of must-read articles, expert insights, and essential topics—from AI and digital twins to single-use technologies and PAT. Ideal for professionals looking to deepen their knowledge and stay ahead in a rapidly evolving field.
Need a refresher on terms and acronyms? Check out our quick-reference Biopharma 4.0 glossary.
Want to see a visual of the key principles of Biopharma 4.0? Download our Biopharma 4.0 model graphic.
